pipette
ENEnglish

Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo

S. Merritt, J. Kindrachuk, D. Nkamba, N. A. Hoff, H. Kalengi, M. Halbrook, L. Kamba, M. Beya, S. Petrichko, H. L. Wallace, C. Luhata, D. Kaba, A. W. Rimoin

PreprintUso en el mundo realFácil de leer

En palabras de los autores

We report general acceptance (79.0%) of Ebola vaccination in the Democratic Republic of the Congo (DRC) between 2023-2024 (n=5,062). Acceptance varied significantly by province with acceptance ranging from 47.6% in Kongo Central to 92.1% in Tshuapa province and was highest among healthcare workers. While Ebola vaccine acceptance and disease knowledge are relatively strong nationally in the DRC, regional differences do exist and may impact future vaccine rollout.

Resultado principalLimitación que admiten los autores

Apareció: martes, 20 de octubre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.15.26365673